Moonwalk Biosciences
Precision epigenetic medicines
Moonwalk Biosciences is an early-stage therapeutics company co-founded by Dr. Feng Zhang and leading experts in cell state epigenetics including Alex Aravanis, the former CTO of Illumina. The company has developed a differentiated approach to mapping the epigenome of cellular states at the whole genome, single cell resolution level, as well as proprietary strategies for precise epigenetic engineering. The combination enables both a novel discovery platform and a path to developing therapeutics that include both epigenetic engineering and other traditional modalities.
Visit website: https://moonwalk.bio/
Details last updated 05-Jan-2024
Moonwalk Biosciences News
Epigenetic remodelling startup 'Moonwalks' out with $57M to develop targeted therapies
Longevity Technology - 04-Jan-2024
This, they claim, is safer and more precise than traditional gene editing methods
Read more...